Literature DB >> 22553597

Congenital membranous cataract associated with persistent fetal vasculature.

Zong-Duan Zhang1, Li-Jun Shen, Jia Qu.   

Abstract

A 15-year-old boy underwent phacoemulsification for a membranous cataract during which the presence of anterior persistent hyaloid artery and elongated ciliary processes were discovered. A posterior capsulorhexis was performed and the anterior part of the persistent hyaloid artery stalk was resected together with the posterior capsule. A foldable intraocular lens was implanted and the optic was captured in the posterior capsulorhexis margin. This is an unusual case of congenital membranous cataract associated with malformations of persistent fetal vasculature and elongated ciliary processes.

Entities:  

Keywords:  congenital membranous cataract; elongated ciliary processes; persistent fetal vasculature

Year:  2010        PMID: 22553597      PMCID: PMC3340740          DOI: 10.3980/j.issn.2222-3959.2010.04.24

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  13 in total

Review 1.  Intraocular lens optic capture.

Authors:  Howard V Gimbel; Brian M DeBroff
Journal:  J Cataract Refract Surg       Date:  2004-01       Impact factor: 3.351

Review 2.  Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture.

Authors:  M F Goldberg
Journal:  Am J Ophthalmol       Date:  1997-11       Impact factor: 5.258

3.  Posterior capsulorhexis with optic capture: maintaining a clear visual axis after pediatric cataract surgery.

Authors:  H V Gimbel; B M DeBroff
Journal:  J Cataract Refract Surg       Date:  1994-11       Impact factor: 3.351

4.  Intraocular lens implantation in a child with monocular cataract and anterior persistent hyperplastic primary vitreous.

Authors:  S Morita; Y Kora; K Takahasi; H Fukai; H Hayashi
Journal:  J Cataract Refract Surg       Date:  2001-03       Impact factor: 3.351

5.  Posterior capsulectomy in pediatric cataract surgery: the necessity of a choice.

Authors:  D BenEzra; E Cohen
Journal:  Ophthalmology       Date:  1997-12       Impact factor: 12.079

6.  Persistent hyperplastic primary vitreous: diagnosis, treatment and results.

Authors:  Z F Pollard
Journal:  Trans Am Ophthalmol Soc       Date:  1997

7.  Role of optic capture in congenital cataract and intraocular lens surgery in children.

Authors:  A R Vasavada; R H Trivedi
Journal:  J Cataract Refract Surg       Date:  2000-06       Impact factor: 3.351

8.  Membranous cataract in association with aniridia.

Authors:  K Yoshikawa; H Asakage; Y Inoue
Journal:  Jpn J Ophthalmol       Date:  1993       Impact factor: 2.447

9.  Surgery in unilateral congenital cataract caused by persistent fetal vasculature or minimal fetal vascular remnants: age-related findings and management challenges.

Authors:  Andrea Müllner-Eidenböck; Michael Amon; Wolfgang Hauff; Nina Klebermass; Claudette Abela; Elisabeth Moser
Journal:  J Cataract Refract Surg       Date:  2004-03       Impact factor: 3.351

10.  Persistent fetal vasculature and minimal fetal vascular remnants: a frequent cause of unilateral congenital cataracts.

Authors:  Andrea Müllner-Eidenböck; Michael Amon; Elisabeth Moser; Nina Klebermass
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

View more
  2 in total

1.  Congenital cataract associated with persistent hyperplastic primary vitreous and persistent tunica vasculosa lentis in a sambar deer (Rusa unicolor) - clinical, ultrasonographic, and histological findings.

Authors:  André Tavares Somma; Christiane Montenegro Coimbra Moura; Rogério Ribas Lange; Renan Schiebel Medeiros; Fabiano Montiani-Ferreira
Journal:  Clin Case Rep       Date:  2016-05-26

2.  Clinical Characteristics and Surgical Procedures for Children with Congenital Membranous Cataract.

Authors:  Jingji Long; Daoman Xiang; Zheng Guo; Lihong Chen; Feng Chen; Jianxun Wang; Wanhua Xie; Shiping He
Journal:  J Ophthalmol       Date:  2017-11-23       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.